Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof

Details for Australian Patent Application No. 2004286855 (hide)

Owner Wyeth

Inventors Dulin, Wendy Ann; Zhuang, Kai; Lin, Yanning; Benjamin, Eric Joel

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004286855

PCT Pub. Number WO2005/044262

Priority 60/515,315 29.10.03 US

Filing date 28 October 2004

Wipo publication date 19 May 2005

Acceptance publication date 21 April 2011

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/044262 Priority application(s): WO2005/044262

21 April 2011 Application Accepted

  Published as AU-B-2004286855

18 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004286857-Fused phenylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

2004286852-Transdermal analgesic systems having reduced abuse potential